Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report - Hypertension pulmonaire : physiopathologie et innovation thérapeutique Accéder directement au contenu
Article Dans Une Revue JTO Clinical and Research Reports Année : 2022

Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report

Fichier principal
Vignette du fichier
S2666364322000431.pdf (581.94 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04521699 , version 1 (22-07-2024)

Licence

Identifiants

Citer

Mariona Riudavets, Benjamin Wyplosz, Maria Rosa Ghigna, Angela Botticella, Pamela Abdayem, et al.. Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report. JTO Clinical and Research Reports, 2022, 3 (5), pp.100319. ⟨10.1016/j.jtocrr.2022.100319⟩. ⟨hal-04521699⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More